Crystalvue Medical Corporation

Total Valuation

Crystalvue Medical Corporation carries a market capitalization of 1.87B, placing it among publicly traded companies globally. Its enterprise value stands at 1.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Crystalvue Medical Corporation currently has 25.34M shares outstanding.

Valuation Ratios

Crystalvue Medical Corporation trades at a trailing price-to-earnings ratio of 17.16. The price-to-sales ratio is 2.58, and the price-to-book ratio stands at 2.64.

Enterprise Valuation

On an enterprise value basis, Crystalvue Medical Corporation trades at an EV/EBITDA multiple of 12.41 and an EV/FCF ratio of 9.22. The EV/Sales ratio of 2.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.41 provides insight into valuation relative to core operating earnings.

Financial Position

Crystalvue Medical Corporation maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.14, indicating moderate leverage, while an interest coverage ratio of 416.91 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Crystalvue Medical Corporation posts a return on equity of 16.22 and a return on invested capital of 11.73.

Taxes

Over the trailing twelve months, Crystalvue Medical Corporation has paid 23.36M in income taxes, reflecting an effective tax rate of 17.22.

Stock Price Statistics

Crystalvue Medical Corporation's stock has declined approximately -13.61502% over the past 52 weeks. The 50-day moving average sits at 70.78, while the 200-day moving average is 75.93.

Income Statement

Over the trailing twelve months, Crystalvue Medical Corporation generated 748.12M in revenue and converted that into 112.29M in net income, yielding earnings per share of 4.40. EBITDA reached 145.50M, while operating income came in at 145.50M.

Balance Sheet

Crystalvue Medical Corporation holds 132.02M in cash and equivalents against 11.70M in total debt, resulting in a net debt position of -132.02M. Total book value stands at 730.86M, with working capital of 379.79M providing operational flexibility.

Cash Flow

Crystalvue Medical Corporation produced 74.13M in operating cash flow over the past twelve months. After subtracting -121.45M in capital expenditures, free cash flow totaled -47.32M - equivalent to -1.87 per share.

Margins

Crystalvue Medical Corporation operates with a gross margin of 35.08, reflecting its pricing power and cost economics. The operating margin of 19.45 and net profit margin of 15.01 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Crystalvue Medical Corporation's most recent stock split took place on July 25, 2023 with a 20:21 split ratio.

Scores

Crystalvue Medical Corporation posts an Altman Z-Score of 6.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.